Cargando…
Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells
Non-small cell lung cancer (NSCLC) is the most prevalent type of cancer and the leading cause of cancer-related death. Chemotherapeutic resistance is a major obstacle in treating NSCLC patients. Here, we discovered that the E3 ligase Skp2 is overexpressed, accompanied by the downregulation of necrop...
Autores principales: | Zhou, Huiling, Zhou, Li, Guan, Qing, Hou, Xuyang, Wang, Cong, Liu, Lijun, Wang, Jian, Yu, Xinfang, Li, Wei, Liu, Haidan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397346/ https://www.ncbi.nlm.nih.gov/pubmed/37532777 http://dx.doi.org/10.1038/s42003-023-05166-6 |
Ejemplares similares
-
Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer
por: Yu, Xinfang, et al.
Publicado: (2022) -
Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth
por: Zhou, Li, et al.
Publicado: (2019) -
Epithelial-mesenchymal reprogramming by KLF4-regulated Rictor expression contributes to metastasis of non-small cell lung cancer cells
por: Zhou, Huiling, et al.
Publicado: (2022) -
RIP1/RIP3/MLKL-mediated necroptosis contributes to vinblastine-induced myocardial damage
por: Zhou, Huiling, et al.
Publicado: (2020) -
RNA modification in cardiovascular disease: implications for therapeutic interventions
por: Wang, Cong, et al.
Publicado: (2023)